BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 37501626)

  • 1. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and COVID-19: is there a connection?
    AlMuhaissen S; Abu Libdeh A; ElKhatib Y; Alshayeb R; Jaara A; Bardaweel SK
    Curr Med Res Opin; 2023 Aug; 39(8):1119-1126. PubMed ID: 37501626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID.
    Tokumasu K; Honda H; Sunada N; Sakurada Y; Matsuda Y; Yamamoto K; Nakano Y; Hasegawa T; Yamamoto Y; Otsuka Y; Hagiya H; Kataoka H; Ueda K; Otsuka F
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888568
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study.
    Domingo JC; Battistini F; Cordobilla B; Zaragozá MC; Sanmartin-Sentañes R; Alegre-Martin J; Cambras T; Castro-Marrero J
    J Transl Med; 2024 Apr; 22(1):343. PubMed ID: 38600563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
    Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
    JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.
    Sanal-Hayes NEM; Mclaughlin M; Hayes LD; Mair JL; Ormerod J; Carless D; Hilliard N; Meach R; Ingram J; Sculthorpe NF
    J Transl Med; 2023 Oct; 21(1):720. PubMed ID: 37838675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
    Retornaz F; Rebaudet S; Stavris C; Jammes Y
    J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lv Y; Zhang T; Cai J; Huang C; Zhan S; Liu J
    Front Immunol; 2022; 13():952987. PubMed ID: 36189286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Campen CLMCV; Rowe PC; Visser FC
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatigue and symptom-based clusters in post COVID-19 patients: a multicentre, prospective, observational cohort study.
    Cornelissen MEB; Bloemsma LD; Vaes AW; Baalbaki N; Deng Q; Beijers RJHCG; Noij LCE; Houweling L; Bazdar S; Spruit MA; Maitland-van der Zee AH;
    J Transl Med; 2024 Feb; 22(1):191. PubMed ID: 38383493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
    Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
    J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.
    Wong TL; Weitzer DJ
    Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33925784
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses.
    Nunes JM; Kell DB; Pretorius E
    Blood Rev; 2023 Jul; 60():101075. PubMed ID: 36963989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
    Toogood PL; Clauw DJ; Phadke S; Hoffman D
    Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myalgic encephalomyelitis/chronic fatigue syndrome: an overview of current evidence].
    Ludwig B; Olbert E; Trimmel K; Seidel S; Rommer PS; Müller C; Struhal W; Berger T
    Nervenarzt; 2023 Aug; 94(8):725-733. PubMed ID: 36695893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care.
    Nacul LC; Lacerda EM; Pheby D; Campion P; Molokhia M; Fayyaz S; Leite JC; Poland F; Howe A; Drachler ML
    BMC Med; 2011 Jul; 9():91. PubMed ID: 21794183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study.
    Słomko J; Newton JL; Kujawski S; Tafil-Klawe M; Klawe J; Staines D; Marshall-Gradisnik S; Zalewski P
    BMJ Open; 2019 Mar; 9(3):e023955. PubMed ID: 30850404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical analysis of the proposal of the Institute of Medicine to replace myalgic encephalomyelitis and chronic fatigue syndrome by a new diagnostic entity called systemic exertion intolerance disease.
    Twisk FN
    Curr Med Res Opin; 2015; 31(7):1333-47. PubMed ID: 25912615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
    Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].
    Renz-Polster H; Scheibenbogen C
    Inn Med (Heidelb); 2022 Aug; 63(8):830-839. PubMed ID: 35925074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.